Evidence mapPaperPMID 42395465Full record

ArticlebioRxiv : the preprint server for biology2026

A p53-ΔNp73 signaling axis drives selective motor neuron degeneration in spinal muscular atrophy.

Maria J Carlini, Xuemei Hu, Leonie Sowoidnich, Archana Yadav, Jason Q Garcia, Maria Savin, Charlotte J Sumner, Vilas Menon, Christian M Simon, Livio Pellizzoni

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria J CarliniDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Xuemei HuDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Leonie SowoidnichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Archana YadavDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Jason Q GarciaDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Maria SavinDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Charlotte J SumnerDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21 21205, USA.
Vilas MenonDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Christian M SimonCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Livio PellizzoniDepartment of Neurology, Columbia University, New York, NY, 10032, USA.ORCID 0000-0002-9168-5628

Funding

Essential role of Stasimon in motor circuit development and diseaseR01NS114218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2021 to 2024
$2.3M
Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$1.0M
Mechanisms and therapeutic targeting of motor neuron death in SMAR01NS116400 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2022 to 2023
$945k
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular AtrophyR01NS102451 · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$585k
NINDS NIH HHS R01 NS102451NINDS NIH HHS R01 NS114218NINDS NIH HHS R01 NS116400NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Selective neuronal vulnerability is a hallmark of many neurodegenerative diseases, yet how ubiquitous genetic insults cause highly selective neuronal loss remains poorly understood. In spinal muscular atrophy (SMA), reduced SMN levels trigger degeneration of specific motor neuron pools. Although non-apoptotic, p53-mediated death pathways have been implicated, p53 is expressed in both vulnerable and resistant neurons, leaving the downstream determinants of selective vulnerability unresolved. Here, we identify a p53-ΔNp73 signaling axis as a previously unrecognized execution pathway driving motor neuron degeneration. Using differential transcriptional profiling of SMA motor neurons following pharmacological modulation of p53 activity, we uncover p73 as a critical downstream mediator of neuronal death. Notably, SMN deficiency induces cell-autonomous, p53-dependent expression of the ΔNp73 isoform selectively in vulnerable, but not resistant, motor neurons. ΔNp73 induction precisely parallels the spatial and temporal pattern of degeneration in mouse models and is also detected in motor neurons from SMA patients. Strikingly, despite its established role as a pro-survival antagonist of p53, depletion of ΔNp73 improves motor neuron survival and partially preserves neuromuscular junction integrity in SMA mice. These findings reveal a context-dependent, isoform-specific functional switch in p53 family signaling that redirects a canonical survival factor into a driver of neurodegeneration, identifying a novel molecular mechanism underlying selective neuronal vulnerability in SMA and a potential therapeutic target for neuroprotection.

Identifiers

PMID42395465
PMCPMC13321005

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.